[Guidelines of DGVS. Remission. German Society of Digestive and Metabolic Diseases].
Kruis
W
W
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D003093:Colitis, Ulcerative / Q000175:diagnosis / Q000628:therapy*; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D019804:Mesalamine / Q000008:administration & dosage / Q000009:adverse effects; D013256:Steroids; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D013256:Steroids; D019804:Mesalamine
Leitlinien der DGVS. Remission.